The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Suppression of Clostridium difficile in the Gastrointestinal Tracts of Germfree Mice Inoculated with a Murine Isolate from the Family Lachnospiraceae
Open accessAbstract
The indigenous microbial community of the gastrointestinal (GI) tract determines susceptibility to Clostridium difficile colonization and disease. Previous studies have demonstrated that antibiotic-treated mice challenged with C. difficile either developed rapidly lethal C. difficile infection or were stably colonized with mild disease. The GI microbial community of animals with mild disease was dominated by members of the bacterial family Lachnospiraceae, while the gut community in moribund animals had a predominance of Escherichia coli. We investigated the roles of murine Lachnospiraceae and E. coli strains in colonization resistance against C. difficile in germfree mice. Murine Lachnospiraceae and E. coli isolates were cultured from wild-type mice. The ability of each of these isolates to interfere with C. difficile colonization was tested by precolonizing germfree mice with these bacteria 4 days prior to experimental C. difficile challenge. Mice precolonized with a murine Lachnospiraceae isolate, but not those colonized with E. coli, had significantly decreased C. difficile colonization, lower intestinal cytotoxin levels and exhibited less severe clinical signs and colonic histopathology. Infection of germfree mice or mice precolonized with E. coli with C. difficile strain VPI 10463 was uniformly fatal by 48 h, but only 20% mortality was seen at 2 days in mice precolonized with the Lachnospiraceae isolate prior to challenge with VPI 10463. These findings confirm that a single component of the GI microbiota, a murine Lachnospiraceae isolate, could partially restore colonization resistance against C. difficile. Further study of the members within the Lachnospiraceae family could lead to a better understanding of mechanisms of colonization resistance against C. difficile and novel therapeutic approaches for the treatment and prevention of C. difficile infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore successful FMT restores members of Lachnospiraceae and other butyrate producing organisms supporting their potential role in outcompeting C. difficile.50”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [50]
In the citing paper
“Additionally, changes in microbial community structure such as restoration of key Firmicutes and Bacteroidetes species with a decrease in Proteobacteria appear to be required in order to outcompete C. difficile.50”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [50]
In the citing paper
“An important factor determining success of fecal transplant is restoration of microbial diversity following treatment50.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [50]
In the citing paper
“Bacterial strains [54, 118, 119] and metabolites [54] associated with protection from C. difficile have now been identified”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [119]
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Colonic Health: Fermentation and Short Chain Fatty Acids
Wong, J. M. W., de Souza, R., Kendall, C. W. C., Emam, A., & Jenkins, D. J. A. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200603000-00015 · Cited by 2,739
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277
Louis, P., & Flint, H. J. (2009) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2009.01514.x · Cited by 2,179
Collins, M. D., Lawson, P. A., Willems, A., Córdoba, J. J., Fernández‐Garayzábal, J. F., GARCIA, P., Cai, J., Hippe, H., & Farrow, J. A. E. (1994) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-44-4-812 · Cited by 1,690
The microbiology of butyrate formation in the human colon
Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S., & Flint, H. J. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11467.x · Cited by 1,320
Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut
Barcenilla, A., Pryde, S. E., Martin, J. C., Duncan, S. H., Stewart, C. S., Henderson, C., & Flint, H. J. (2000) · Applied and Environmental Microbiology · doi:10.1128/aem.66.4.1654-1661.2000 · Cited by 996
Colonization resistance of the digestive tract in conventional and antibiotic-treated mice
van der Waaij, D., Vries, J. M. B.-D., & der Wees, J. E. C. L.-V. (1971) · Journal of Hygiene · doi:10.1017/s0022172400021653 · Cited by 907
INTESTINAL FLORA IN NEW-BORN INFANTS
Hall, I. C. (1935) · American journal of diseases of children · doi:10.1001/archpedi.1935.01970020105010 · Cited by 766
Cited by
Sorted by citations
Items 101–200 of 305
Ge, L., Qi, J., Shao, B., Ruan, Z., Ren, Y., Sui, S., Wu, X., Sun, X., Liu, S., Li, S., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2021.2013764 · Cited by 69
Gut microbial alterations in arginine metabolism determine bone mechanical adaptation
Wang, D., Cai, J., Pei, Q., Yan, Z., Zhu, F., Zhao, Z., Liu, R., Guo, X., Sun, T., Liu, J., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.004 · Cited by 64
Sieving through gut models of colonization resistance
Mullineaux-Sanders, C., Suez, J., Elinav, E., & Frankel, G. M. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0095-1 · Cited by 61
Effect of industrial trans-fatty acids-enriched diet on gut microbiota of C57BL/6 mice
Ge, Y., Liu, W., Tao, H., Zhang, Y., Liu, L., Liu, Z., Qiu, B., & Xu, T. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1810-2 · Cited by 64
Wu, X., Zhang, T., Zhang, T., & Park, S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2292254 · Cited by 64
Daniel, S. G., Ball, C. L., Besselsen, D. G., Doetschman, T. C., & Hurwitz, B. L. (2017) · mSystems · doi:10.1128/msystems.00065-17 · Cited by 60
Type 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era
Martínez-López, Y. E., Esquivel-Hernandez, D. A., Sánchez-Castañeda, J. P., Neri-Rosario, D., Guardado‐Mendoza, R., & Reséndis-Antonio, O. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2111952 · Cited by 59
Clostridium difficile, the Difficult “Kloster” Fuelled by Antibiotics
Dicks, L. M. T., Mikkelsen, L. S., Brandsborg, E., & Marcotte, H. (2018) · Current Microbiology · doi:10.1007/s00284-018-1543-8 · Cited by 56
The human microbiota: novel targets for hospital-acquired infections and antibiotic resistance
Pettigrew, M. M., Johnson, J. K., & Harris, A. D. (2016) · Annals of Epidemiology · doi:10.1016/j.annepidem.2016.02.007 · Cited by 55
Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults
Vasilescu, I.-M., Chifiriuc, M. C., Pîrcălăbioru, G. G., Filip, R., Bolocan, A., Lazăr, V., Diţu, L.-M., & Bleoţu, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.651081 · Cited by 53
Wang, X., Xu, M., Xu, D., Ma, K., Zhang, C., Wang, G., Dong, M., & Li, W. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119971 · Cited by 53
Taur, Y., & Pamer, E. G. (2014) · Nature Medicine · doi:10.1038/nm.3492 · Cited by 51
Winston, J. A., Rivera, A. J., Cai, J., Patterson, A. D., & Theriot, C. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246161 · Cited by 51
O’Loughlin, J. L., Samuelson, D. R., Braundmeier‐Fleming, A., White, B. A., Haldorson, G. J., Stone, J. B., Lessmann, J. J., Eucker, T. P., & Konkel, M. E. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.00281-15 · Cited by 49
Oral Delivery of Nisin in Resistant Starch Based Matrices Alters the Gut Microbiota in Mice
Gough, R., Cabrera‐Rubio, R., O’Connor, P. M., Crispie, F., Brodkorb, A., Miao, S., Hill, C., Ross, R. P., Cotter, P. D., Nilaweera, K. N., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01186 · Cited by 52
The gut microbiota in transplant patients
Chong, P. P., & Koh, A. Y. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100614 · Cited by 53
The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity
Lesniak, N. A., Schubert, A. M., Flynn, K. J., Leslie, J. L., Sinani, H., Bergin, I. L., Young, V. B., & Schloss, P. D. (2022) · mBio · doi:10.1128/mbio.01183-22 · Cited by 50
Self-citationPakpour, S., Bhanvadia, A., Zhu, R. C., Amarnani, A., Gibbons, S. M., Gurry, T., Alm, E. J., & Martello, L. A. (2017) · Microbiome · doi:10.1186/s40168-017-0368-1 · Cited by 48
The Gut Microbiome Modulates Body Temperature Both in Sepsis and Health
Bongers, K. S., Chanderraj, R., Woods, R. J., McDonald, R. A., Adame, M. D., Falkowski, N. R., Brown, C. A., Baker, J. M., Winner, K. M., Fergle, D. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202201-0161oc · Cited by 51
Self-citationTherapeutic manipulation of the microbiota: past, present, and considerations for the future
Young, V. B. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.09.001 · Cited by 48
Self-citationAlam, M. S., Gangiredla, J., Hasan, N. A., Barnaba, T. J., & Tartera, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.672353 · Cited by 52
The Challenge and Potential of Metagenomics in the Clinic
Mulcahy, H., & Workentine, M. L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00029 · Cited by 50
Crouzet, L., Rigottier‐Gois, L., & Serror, P. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv012 · Cited by 48
Aktaş, B., Wolfe, T. J. D., Safdar, N., Darien, B. J., & Steele, J. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156374 · Cited by 49
Variation in germination of Clostridium difficile clinical isolates correlates to disease severity
Carlson, P. E., Kaiser, A. M., McColm, S., Bauer, J. M., Young, V. B., Aronoff, D. M., & Hanna, P. C. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.02.003 · Cited by 44
Self-citationMicrobiota-Based Therapies for Clostridium difficile and Antibiotic-Resistant Enteric Infections
Lewis, B. B., & Pamer, E. G. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093549 · Cited by 46
Clostridioides difficile Infection
Stewart, D. B. (2020) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0040-1701228 · Cited by 43
Wei, S., Bahl, M. I., Baunwall, S. M. D., Dahlerup, J. F., Hvas, C. L., & Licht, T. R. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2084306 · Cited by 43
Probiotics: insights and new opportunities for Clostridioides difficile intervention
Pal, R., Athamneh, A. I. M., Deshpande, R., Ramirez, J. A. R., Adu, K. T., Muthuirulan, P., Pawar, S., Biazzo, M., Apidianakis, Y., Sundekilde, U. K., et al. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2072705 · Cited by 44
Yang, Y., Zhong, Z., Wang, B., & Wang, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113902 · Cited by 44
Clostridium difficile Infection
Gerding, D. N., & Young, V. B. (2015) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-1-4557-4801-3.00245-9 · Cited by 44
Self-citationStecher, B. (2021) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2021.151484 · Cited by 41
Li, L., Qiu, N., Meng, Y., Wang, C., Mine, Y., Keast, R., & Guyonnet, V. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.07.021 · Cited by 41
Leslie, J. L., Vendrov, K. C., Jenior, M. L., & Young, V. B. (2019) · mSphere · doi:10.1128/mspheredirect.00698-18 · Cited by 41
Self-citationBacteriophage-mediated modulation of microbiota for diseases treatment
Zhang, Y., Li, C., & Zhang, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113856 · Cited by 42
Akha, A. A. S., Theriot, C. M., Erb‐Downward, J. R., McDermott, A. J., Falkowski, N. R., Tyra, H. M., Rutkowski, D. T., Young, V. B., & Huffnagle, G. B. (2013) · Immunology · doi:10.1111/imm.12122 · Cited by 40
Self-citationYang, H., Santos, M. D. S., Lee, J., Law, H. T., Chimalapati, S., Verdu, E. F., Orth, K., & Vallance, B. A. (2019) · mBio · doi:10.1128/mbio.02608-19 · Cited by 39
Schnizlein, M. K., Vendrov, K. C., Edwards, S. J., Martens, E. C., & Young, V. B. (2020) · mSphere · doi:10.1128/msphere.00708-19 · Cited by 41
Self-citationJose, S., Mukherjee, A., Horrigan, O., Setchell, K. D. R., Zhang, W., Moreno‐Fernandez, M. E., Andersen, H. M., Sharma, D., Haslam, D. B., Divanovic, S., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00338-7 · Cited by 40
Chen, X., Wang, Z., Wang, D., & Kan, J. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.07.060 · Cited by 38
Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection
Adamu, B. O., & Lawley, T. D. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.009 · Cited by 39
Thiemann, S., Smit, N., & Strowig, T. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_504 · Cited by 44
Gut microbiota promotes production of aromatic metabolites through degradation of barley leaf fiber
Li, D., Wang, P., Wang, P., Hu, X., & Chen, F. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.05.001 · Cited by 38
Frisbee, A. L., & Petri, W. A. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.009 · Cited by 42
García-Mazcorro, J. F., Pedreschi, R., Chew, B. P., Dowd, S. E., Kawas, J. R., & Noratto, G. D. (2018) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1803.03020 · Cited by 35
Riddle, M. S., & Connor, B. A. (2016) · Current Infectious Disease Reports · doi:10.1007/s11908-016-0536-7 · Cited by 34
Manuel, C. R., LaTuga, M. S., Ashby, C. R., & Reznik, S. E. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.02.028 · Cited by 34
Etienne‐Mesmin, L., Chassaing, B., Adekunle, O., Mattei, L. M., Bushman, F. D., & Gewirtz, A. T. (2017) · Gut · doi:10.1136/gutjnl-2016-313510 · Cited by 35
Strain-Dependent RstA Regulation of Clostridioides difficile Toxin Production and Sporulation
Edwards, A. N., Krall, E., & McBride, S. M. (2019) · Journal of Bacteriology · doi:10.1128/jb.00586-19 · Cited by 33
Altered Gut Microbiota in Patients With Peutz-Jeghers Syndrome
Wan, S., Huang, G., Wang, J.-X., Tian, L., Zuo, X., Li, Y., & Yu, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.881508 · Cited by 31
Chen, J., Zhang, C., Xia, Q., Liu, D., XingHe, T., Li, Y., & Cao, Y. B. (2020) · Molecules · doi:10.3390/molecules25061302 · Cited by 32
Murine models to study Clostridium difficile infection and transmission
Lawley, T. D., & Young, V. B. (2013) · Anaerobe · doi:10.1016/j.anaerobe.2013.09.008 · Cited by 31
Self-citationFaecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection
Koenigsknecht, M. J., & Young, V. B. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328365d326 · Cited by 30
Self-citationCurry, S. R. (2017) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2017.01.007 · Cited by 29
Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection
Smith, A. D., Foss, E. D., Zhang, I., Hastie, J. L., Giordano, N. P., Gasparyan, L., VinhNguyen, L. P., Schubert, A. M., Prasad, D., McMichael, H. L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223025 · Cited by 30
Zhang, B., Ren, D., Zhao, A., Shao, H., Li, T., Niu, P., Zhao, Y., & Yang, X. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05464 · Cited by 28
Age Matters: Community Assembly in the Pig Fecal Microbiome in the First Month of Life
Jurburg, S. D., & Bossers, A. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.564408 · Cited by 25
Dong, Q., Lin, H., Allen, M.-M., Garneau, J. R., Sia, J. K., Smith, R. C., Haro, F., McMillen, T. A., Pope, R. L., Metcalfe, C. K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112861 · Cited by 26
Self-citationForssten, S. D., Röytiö, H., Hibberd, A. A., & Ouwehand, A. C. (2015) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v26.27988 · Cited by 26
Akha, A. A. S., McDermott, A. J., Theriot, C. M., Carlson, P. E., Frank, C. R., McDonald, R. A., Falkowski, N. R., Bergin, I. L., Young, V. B., & Huffnagle, G. B. (2014) · Immunology · doi:10.1111/imm.12414 · Cited by 26
Self-citationKubota, H., Makino, H., Gawad, A., Kushiro, A., Ishikawa, E., Sakai, T., Akiyama, T., Matsuda, K., Martı́n, R., Knol, J., et al. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01540-16 · Cited by 25
Lesniak, N. A., Schubert, A. M., Sinani, H., & Schloss, P. D. (2021) · mSphere · doi:10.1128/msphere.01238-20 · Cited by 26
Mahnič, A., Auchtung, J. M., Ulrih, N. P., Britton, R. A., & Rupnik, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-65253-0 · Cited by 24
Touchefeu, Y., Duchalais, É., Varannes, S. B. D., Alameddine, J., Mirallié, É., Matysiak‐Budnik, T., Bastard, Q. L., Javaudin, F., Rimbert, M., Jotereau, F., et al. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001842 · Cited by 24
Liu, S., Bennett, D. C., Tun, H. M., Kim, J.-E., Cheng, K. M., Zhang, H., & Leung, F. C.-C. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01092 · Cited by 24
Ma, Y., Han, L., Raza, S. H. A., Gui, L., Zhang, X., Hou, S., Sun, S., Yuan, Z., Wang, Z., Yang, B., et al. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3340 · Cited by 23
Wu, Y., Lei, Z., Wang, Y., Yin, D., Aggrey, S. E., Guo, Y., & Yuan, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.683905 · Cited by 22
Panpetch, W., Phuengmaung, P., Cheibchalard, T., Somboonna, N., Leelahavanichkul, A., & Tumwasorn, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.745299 · Cited by 22
Modulation of Allicin-Free Garlic on Gut Microbiome
Chen, K., Nakasone, Y., Xie, K., Sakao, K., & Hou, D. (2020) · Molecules · doi:10.3390/molecules25030682 · Cited by 23
Mohandas, S., Soma, V. L., Tran, T. D. B., Sodergren, E. J., Ambooken, T., Goldman, D. L., Weinstock, G. M., & Herold, B. C. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.583446 · Cited by 25
Exploring the impact of Helicobacter pylori and potential gut microbiome modulation
Ong, I. J., Loo, K.-Y., Law, L. N.-S., Law, J. W., Tan, L. T., & Letchumanan, V. (2023) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000273 · Cited by 20
Characterizing the composition of intestinal microflora by 16S rRNA gene sequencing
Wang, W., Zhou, Y., He, J., Feng, Z., Zhang, L., Lai, X., Zhou, J.-X., & Wang, H. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i6.614 · Cited by 19
Huang, X., Johnson, A., Brehm, J. N., Do, T. V. T., Auchtung, T. A., McCullough, H. C., Lerma, A. I., Haidacher, S. J., Hoch, K. M., Horvath, T. D., et al. (2025) · mSphere · doi:10.1128/msphere.01049-24 · Cited by 21
Meehan, C. J., Langille, M. G. I., & Beiko, R. G. (2015) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000381162 · Cited by 19
Newell‐Fugate, A. E., Lenz, K., Skenandore, C., Nowak, R. A., White, B. A., & Braundmeier‐Fleming, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179542 · Cited by 18
Grimes, L. P., Doyle, A., Miller, A. L., Pyles, R. B., Oláh, G., Szabó, C., Hoskins, S., & Eaves-Pyles, T. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166770 · Cited by 18
Regulation of a New Type of Selenium-Rich Royal Jelly on Gut Microbiota Profile in Mice
Chi, X., Liu, Z., Wang, H., Wang, Y., Xu, B., & Wei, W. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02800-4 · Cited by 17
Clostridium difficile Infection: A Model for Disruption of the Gut Microbiota Equilibrium
Blanchi, J., Goret, J., & Mégraud, F. (2016) · Digestive Diseases · doi:10.1159/000443355 · Cited by 16
Protective Effect of Baicalin against Clostridioides difficile Infection in Mice
Pellissery, A. J., Vinayamohan, P. G., Kuttappan, D. A., Mishra, N., Fragomeni, B. D. O., Maas, K. R., Mooyottu, S., & Venkitanarayanan, K. (2021) · Antibiotics · doi:10.3390/antibiotics10080926 · Cited by 16
Clostridioides difficile carriage in animals and the associated changes in the host fecal microbiota
Thanissery, R., McLaren, M. R., Rivera, A. J., Reed, A. D., Betrapally, N. S., Burdette, T., Winston, J. A., Jacob, M. E., Callahan, B. J., & Theriot, C. M. (2020) · Anaerobe · doi:10.1016/j.anaerobe.2020.102279 · Cited by 21
Sangouni, A. A., Alizadeh, M., Jamalzehi, A., Hosseinzadeh, M., & Parastouei, K. (2023) · Phytotherapy Research · doi:10.1002/ptr.7741 · Cited by 15
Lee, M. D., Pedroso, A. A., Lumpkins, B. S., Cho, Y., & Maurer, J. J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1139321 · Cited by 16
Xu, R., Feng, N., Li, Q., Wang, H., Li, L., Feng, X., Su, Y., & Zhu, W. (2024) · The ISME Journal · doi:10.1093/ismejo/wrae101 · Cited by 16
The metabolic impact of bacterial infection in the gut
Chaukimath, P., Frankel, G. M., & Visweswariah, S. S. (2022) · FEBS Journal · doi:10.1111/febs.16562 · Cited by 14
Barron, M. R., Sovacool, K. L., Close, L. A., Vendrov, K. C., Standke, A. K., Bergin, I. L., Schloss, P. D., & Young, V. B. (2022) · mBio · doi:10.1128/mbio.01904-22 · Cited by 15
Self-citationReviewing the Clostridioides difficile Mouse Model: Insights into Infection Mechanisms
Fachi, J. L., Vinolo, M. A. R., & Colonna, M. (2024) · Microorganisms · doi:10.3390/microorganisms12020273 · Cited by 14
Ouyang, M., Zou, S., Cheng, Q., Shi, X., Zhao, Y., & Sun, M. (2024) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986241260211 · Cited by 14
Wolfe, T. J. D., Kates, A., Barko, L., Darien, B. J., & Safdar, N. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00111-19 · Cited by 14
Fang, M., Hu, W., & Liu, B. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1228360 · Cited by 13
Schenck, L. P. (2015) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v6.i4.169 · Cited by 13
Herrera, G., Paredes‐Sabja, D., Patarroyo, M. A., Ramírez, J. D., & Muñoz, M. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1966277 · Cited by 13
Salicylanilide Analog Minimizes Relapse of Clostridioides difficile Infection in Mice
Blake, S., Thanissery, R., Rivera, A. J., Hixon, M. S., Lin, M., Theriot, C. M., & Janda, K. D. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00123 · Cited by 12
Maslanka, J. R., Gu, C. H., Zarin, I., Denny, J. E., Broadaway, S. C., Fett, B., Mattei, L. M., Walk, S. T., & Abt, M. C. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1851999 · Cited by 12
Optimum health and inhibition of cancer progression by microbiome and resveratrol
Stokes, J. A., III (2020) · Frontiers in bioscience · doi:10.2741/4904 · Cited by 11
Tu, Y., Luo, L., Zhou, Q., Ni, J., & Tang, Q. (2024) · Radiation Research · doi:10.1667/rade-23-00189.1 · Cited by 11
Inhibition of PD‐1 Protects against TNBS‐Induced Colitis via Alteration of Enteric Microbiota
Xu, H., Zhou, Y., Xu, J., Li, Y., Zhao, C., Huang, H., Du, Y., He, J., Zhou, Y.-J., & Nie, Y. (2021) · BioMed Research International · doi:10.1155/2021/4192451 · Cited by 10
A contemporary review of Clostridioides difficile infections in patients with haematologic diseases
Dutta, D., Jafri, F. M., STUHR, D., Knoll, B. M., & Lim, S. H. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13173 · Cited by 13
Systematic discovery of probiotics
Forster, S. C., & Lawley, T. D. (2015) · Nature Biotechnology · doi:10.1038/nbt.3111 · Cited by 11
Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization
Fishbein, S. R. S., DeVeaux, A. L., Khanna, S., Ferreiro, A. L., Liao, J., Agee, W., Ning, J., Mahmud, B., Wallace, M. J., Hink, T., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.12.002 · Cited by 11
Andrei, C., Zanfirescu, A., Ormeneanu, V.-P., & Negreș, S. (2025) · Antibiotics · doi:10.3390/antibiotics14020138 · Cited by 11
Metadata
- Authors
- Reeves, A. E., Koenigsknecht, M. J., Bergin, I. L., & Young, V. B.
- Affiliations
- University of Michigan (US)
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2012-11
- Volume
- 80
- Issue
- 11
- Pages
- 3786-3794
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC3486043
- OpenAlex
- W2122459017
- Cited by
- 292
- References
- 47
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 14 · 2023: 13 · 2022: 25 · 2021: 32 · 2020: 25 · 2019: 23 · 2018: 28 · 2017: 21 · 2016: 23 · 2015: 26 · 2014: 23 · 2013: 18
- FWCI
- 14.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Infection and Immunity (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (U19AI090871, AI090871)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK089503, R01DK070875, P30DK089503)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Clostridium difficile, colonization resistance, Lachnospiraceae, gut microbiota, germ-free mice, Escherichia coli, Clostridium difficile infection, colonic histopathology, antibiotic-treated mice
- MeSH terms
- Animals, Escherichia coli, Germ-Free Life, Mice, Inbred C57BL, Phylogeny, RNA, Ribosomal, 16S, Colony Count, Microbial, Clostridioides difficile, Gram-Positive Endospore-Forming Rods, Gastrointestinal Tract, Mice, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review